Why is Evexia Lifecare falling/rising?

As of 11-Aug, Evexia Lifecare Ltd's stock price is currently at 2.26, reflecting an increase of 0.02 or 0.89%. The stock has shown a trend reversal, gaining after three consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally weak performance. Despite a significant drop in delivery volume by 77.87% compared to the 5-day average, the company has reported positive results for the last five consecutive quarters, with net sales growing at 70.99% for the first nine months. Nevertheless, the company faces challenges such as high debt levels and weak long-term growth, with a debt-to-equity ratio of 2.81 times and an average return on equity of only 0.95%, which suggests low profitability.
In the broader market context, Evexia Lifecare's short-term performance has been relatively poor compared to the benchmark, with a 1-week return of -1.31% against the Sensex's -0.51%. Over the past month, the stock has declined by 4.24%, while the Sensex has only fallen by 2.30%. This underperformance is further highlighted by the stock's year-to-date return of -34.49%, contrasting sharply with the Sensex's gain of 3.15%. The stock's long-term performance has also been disappointing, with a 25.41% decline over the past year, indicating a consistent trend of underperformance relative to broader market indices.